Sigachi Industries Limited

SIGACHI

INE0D0K01022

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-04-26 am EDT			5-day change	1st Jan Change
66.75 ^INR	-0.96%		+6.80%	+29.86%

Apr. 06	Sigachi Industries Limited Announces Resignation of Shreya Mitra as Company Secretary & Compliance Officer	CI
Feb. 27	Sigachi MENA FZCO Unit, iConsult Establish Joint Venture for UAE Business	MT

Sigachi Industries Limited announced that it has received INR 716.11875 million in funding from a group of investors

November 13, 2023

Sigachi Industries Limited has allotted 10,975,000 Convertible Warrants at an issue price of INR 65.25 to Promoters and Non Promoters on November 14, 2023. The company can receive the funds against such warrants in one or more tranches.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	DHOOT INDUSTRIAL FINANCE LIMITED	265.8 INR	+1.41%	+3.67%	20.13M
	SIGACHI INDUSTRIES LIMITED	66.75 INR	-0.96%	+6.80%	259M

Latest news about Sigachi Industries Limited

Sigachi Industries Limited Announces Resignation of Shreya Mitra as Company Secretary & Compliance Officer	Apr. 06	CI
Sigachi MENA FZCO Unit, iConsult Establish Joint Venture for UAE Business	Feb. 26	MT
Sigachi MENA FZCO, A Wholly Owned Subsidiary of the Sigachi Industries Limited and iConsult Trading Consultancy LLC Announce Formation of Joint Venture, Sigachi Global	Feb. 26	CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 19	CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Sigachi Industries Limited announced that it has received INR 716.11875 million in funding from a group of investors	Nov. 13	CI
Sigachi Industries' Dubai-based Arm to Form Saudi Arabian JV	23-10-19	MT
Sigachi Industries Limited Declares Dividend for the Financial Year 2022-23	23-09-07	CI
Sigachi Industries Sets Up New Corporate Office in Hyderabad, India	23-08-30	MT
Sigachi Industries Limited Announces Opening of New Corporate Office	23-08-30	CI
Sigachi Industries Limited Recommends Dividend for the Financial Year 2022-23	23-08-16	CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Sigachi Industries Limited agreed to acquire 80% stake in Trimax Bio Sciences Private Limited for INR 1 billion.	23-08-09	CI
Sigachi Industries' Consolidated Profit Plummets in Fiscal Q4	23-05-25	MT
Sigachi Industries Limited Recommends Dividend	23-05-25	CI
Sigachi Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-25	CI
Sigachi Looks to Acquire API Units for Forward Integration	23-04-06	CI
Sigachi Industries Limited Announces Resignation of Mohankrishna Reddy Arvabumi as Director	23-02-16	CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-30	CI
Sigachi Industries Limited Approves Board Changes	23-01-10	CI
CARE Retains A- Rating on Sigachi Industries' Long-term Bank Financing; Outlook Stable	23-01-05	MT
Certain Equity Shares of Sigachi Industries Limited are subject to a Lock-Up Agreement Ending on 10-NOV-2022.	22-11-09	CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-27	CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-22	CI
Sigachi Industries Limited Announces Launch of Health Care Division	22-07-22	CI

Chart Sigachi Industries Limited

Duration

Period

More charts

Company Profile

Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Companyâs products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The Company's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. It produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The Company offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. It operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The Company serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SIGACHI INDUSTRIES LIMITED	+29.86%	259M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals